Skip to main content
OpenTrials

Clinical trial condition

Chronic Lymphocytic Leukemia

Explore clinical trials studying Chronic Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.

526 public trials 91 recruiting studies
Refine in advanced search Browse all conditions

Chronic Lymphocytic Leukemia trial results

Completed

Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia

NCT02827617

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Onco Ematologia Clinico Sperimentale, I.R.C.C.S. Centro di Riferimento Oncologico Aviano, Italy
  • Ospedale San Raffaele Milan, Italy
  • Dipartimento di Ematologia, Niguarda Cancer Center, Ospedale Niguarda Milan, Italy
  • Department of Medical and Surgical Sciences, section of Hematology Modena, Italy
View all 13 locations
View Trial Details
Completed

Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies

NCT02290951

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +20 more
Locations
  • University of California, Irvine Orange, California, United States
  • Stanford University Stanford, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 22 locations
View Trial Details
Completed

Financial Difficulty in Patients With Blood Cancer

NCT05212233

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +22 more
Locations
  • University Of Alabama At Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Savannah, Georgia, United States
  • LSU Health Baton Rouge-North Clinic Baton Rouge, Louisiana, United States
View Trial Details
Completed

BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I)

NCT04018248

Conditions
B Cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +36 more
Locations
  • Henry Ford Hospital Detroit, Michigan, United States
  • National Cancer Center Goyang-si, Gyeonggi-do, South Korea
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
  • Chonnam National University Hwasun Hospital Hwasun, Jeollanam-do, South Korea
View Trial Details
Completed

A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

NCT04657224

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations
  • Stony Brook University Medical Center Stony Brook, New York, United States
  • Monash Medical Centre Clayton, Australia
  • Peter MacCallum Cancer Centre Melbourne, Australia
  • Linear Clinical Research Ltd Nedlands, Australia
View all 28 locations
View Trial Details
Completed

A Study to Assess Change in Patient Experience in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets + Intravenous Rituximab or Bruton's Tyrosine Kinase Inhibitors Tablets in the United Kingdom

NCT05555979

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Barts Health NHS Trust /ID# 252717 London, London, City of, United Kingdom
  • Norfolk and Norwich University Hospitals NHS Foundation Trust /ID# 252720 Norwich, Norfolk, United Kingdom
  • Nottingham City Hospital /ID# 252716 Nottingham, Nottinghamshire, United Kingdom
  • Oxford University Hospitals NHS Foundation Trust /ID# 252715 Oxford, Oxfordshire, United Kingdom
View Trial Details

Related conditions